Zhang Z, et al. – The objective of this study was to detect preclinical efficacy and molecular mechanism of targeting CDK7–dependent transcriptional addiction in ovarian cancer. In this study, the molecular underpinnings of THZ1 potency had been unveiled. Findings established pharmaceutically targeting transcriptional addiction as a promising therapeutic strategy in aggressive ovarian cancer.